Apitope is a startup based in Belgium, most recent round Acquired, 1 tracked investor.
Apitope is a startup founded in 2004 based in Belgium. Apitope has been acquired. Brouky records 1 investor associated with the company.
Apitope was a clinical-stage biotechnology company developing novel peptide therapeutics, called 'apitopes', to treat autoimmune diseases such as multiple sclerosis and Graves' disease. Its proprietary technology platform generated highly specific, immunomodulatory peptides.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.